Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vitamin D Supplementation in Valve Replacement Surgery
NCT04085770Phase 4Completed
- Sponsor
- Cairo University
- Start
- Apr 2017
- Primary completion
- Feb 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of alfacalcidol in postoperative complication (2 arms), sponsored by Cairo University. Primary endpoints: Hospital Length of Stay up to 15 days and Intensive Care Unit Length of Stay up to 7 days. Started Apr 2017; status: completed.
02
Drugs
alfacalcidol
03
Conditions
postoperative complication
Beyond the preview
Go deeper on NCT04085770.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04085770.